W. Va. Code R. § 64-85-7 - Behavior Management
7.1.
The alzheimer's/dementia special care unit or program shall conduct and
document an ongoing evaluation of any resident with behaviors, which are
persistent and constitute sources of distress or dysfunction to the resident,
or present a danger to the resident or other individuals. The evaluation shall
determine the following:
7.1.a. A baseline of
the intensity, duration, and frequency of the behavior;
7.1.b. Antecedent behaviors and
activities;
7.1.c. Recent changes
or risk factors in the resident's life;
7.1.d. Environment factors such as time of
day, staff involved, noise, levels etc.;
7.1.e. The resident's medical
status;
7.1.f. Staffing patterns at
times of inappropriate behavior;
7.1.g. Alternative, structured activities or
behaviors that have been successful or unsuccessful in the past; and
7.1.h. The effectiveness of behavioral
management approaches.
7.2. The facility shall implement a less
restrictive, systematic, non-medication behavioral management approach to
assist a resident prior to obtaining orders for psychotropic or behavioral
modifying medications.
7.3. The
facility shall ensure that any resident receiving a psychotropic or behavioral
modifying medication shall:
7.3.a. Have that
medication administered in a dose based on the age recommendations of the
individual;
7.3.b. Have a diagnosed
and documented condition justifying the use of the medication;
7.3.c. Receive daily monitoring for any side
effects or adverse reaction to the medication;
7.3.d. Have adverse findings reported to the
resident's physician immediately; and
7.3.e. Have periodic dose reductions in the
medication in an attempt to discontinue the medication unless the physician has
determined that a dose reduction is contraindicated, based on the resident's
condition.
7.4. A
registered professional nurse or other appropriate licensed health care
professional shall evaluate all residents receiving psychotropic or behavioral
modifying medications monthly to assess the resident's functional level,
identify potential adverse effects of the medication and consult with the
resident's physician to determine if the medication should be
continued.
7.5. The resident's
physician shall document in the resident's medical record every six (6) months
a reassessment and determination for the continued use of the medications and
reasons a dose reduction would be contraindicated.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.